Effect of feeding calcium gluconate embedded in a hydrogenated fat matrix on feed intake, gastrointestinal fermentation and morphology, intestinal brush border enzyme activity and blood metabolites in growing lambs.


Journal

Journal of animal science
ISSN: 1525-3163
Titre abrégé: J Anim Sci
Pays: United States
ID NLM: 8003002

Informations de publication

Date de publication:
01 Aug 2022
Historique:
received: 18 02 2022
accepted: 31 05 2022
pubmed: 3 6 2022
medline: 23 8 2022
entrez: 2 6 2022
Statut: ppublish

Résumé

Gluconate salts have been identified as a butyrate precursor when fed to non-ruminant species and may increase the butyrate concentration in the large intestine supporting gastrointestinal health and development. The objective of this study was to evaluate the dose response of hydrogenated fat-embedded calcium gluconate (HFCG) on performance and gastrointestinal tract (GIT) development in growing lambs. Thirty-two wether lambs were used in a randomized complete block design and assigned to 1 of 4 treatments differing in the inclusion of HFCG: 0.0% (CON), 0.075% (LOW), 0.30% (MED), and 0.60% of the diet (HIGH). Lambs were allocated into individual pens and fed ad libitum with feed delivered twice daily. Feed intake was recorded daily, and body weight (BW) was assessed at the beginning and the end of the 29-d period. Blood was sampled on day 21, prior to feeding and 6 h post-feeding to evaluate changes in β-hydroxybutyrate, glucose, and insulin concentrations. Total fecal collection was conducted during days 25 to 28 to assess apparent total tract digestibility. On day 29, lambs were slaughtered, and the entire GIT was separated by region to enable sampling of tissue and digesta. Data were analyzed to assess linear, quadratic, and cubic effects of HFCG dose. Final BW, average daily gain, and dry matter intake decreased linearly (P ≤ 0.02) with increasing HFCG. Increasing inclusion of HFCG linearly decreased (P = 0.01) the thickness of the stratum corneum in ruminal papillae but did not affect other strata (P ≥ 0.34). Omasal digesta weight linearly decreased (P = 0.01) as the concentration of HFCG increased and abomasal digesta weight was cubically affected (P = 0.03) the increasing dose of HFCG. Short-chain fatty acid concentration in the cecum was cubically affected (P < 0.01) with increasing dose of HFCG where low dose had the greatest concentration. Moreover, increasing the dietary supply of HFCG linearly increased the proportion of acetate (P = 0.04) in the cecum and linearly decreased the proportion of propionate in the digesta of both the cecum (P < 0.01) and colon (P = 0.01). Colon crypt depth was quadratically (P = 0.03) affected with the increasing dose of HFCG, where lambs fed MED had greatest crypt depth. We conclude that feeding HFCG to growing lambs did not increase butyrate concentration in the large intestine and consequently does not increase the absorptive surface area of the whole tract, the size of the GIT, or the functionality of the intestine. Gluconate salts have been reported to be metabolized by microbes in the gastrointestinal tract to yield butyrate. Butyrate has shown potential to enhance functionality of the gastrointestinal tract by increasing the absorptive surface area, enzyme activity, and the barrier function. This study evaluated the inclusion of four levels of hydrogenated fat-embedded Ca-gluconate (HFCG; 0.0%, 0.075%, 0.30%, and 0.60% of the diet) designed to increase the production of butyrate in the large intestine. Thirty-two wether lambs were fed for 28 d, slaughtered, and eviscerated to allow complete evaluation of the gastrointestinal tract and its contents. Growth and dry matter intake decreased linearly with increasing dose of HFCG. Dose of HFCG cubically affected short-chain fatty acid concentration in the cecum with increased concentrations at the 0.075% dose. Moreover, increasing dose of HFCG linearly increased the proportion of acetate and linearly decreased the proportion of propionate in the cecum without altering the proportion of butyrate. Thus, the supplementation of HFCG did not increase butyrate concentration in the large intestine and did not enhance gastrointestinal tract function.

Autres résumés

Type: plain-language-summary (eng)
Gluconate salts have been reported to be metabolized by microbes in the gastrointestinal tract to yield butyrate. Butyrate has shown potential to enhance functionality of the gastrointestinal tract by increasing the absorptive surface area, enzyme activity, and the barrier function. This study evaluated the inclusion of four levels of hydrogenated fat-embedded Ca-gluconate (HFCG; 0.0%, 0.075%, 0.30%, and 0.60% of the diet) designed to increase the production of butyrate in the large intestine. Thirty-two wether lambs were fed for 28 d, slaughtered, and eviscerated to allow complete evaluation of the gastrointestinal tract and its contents. Growth and dry matter intake decreased linearly with increasing dose of HFCG. Dose of HFCG cubically affected short-chain fatty acid concentration in the cecum with increased concentrations at the 0.075% dose. Moreover, increasing dose of HFCG linearly increased the proportion of acetate and linearly decreased the proportion of propionate in the cecum without altering the proportion of butyrate. Thus, the supplementation of HFCG did not increase butyrate concentration in the large intestine and did not enhance gastrointestinal tract function.

Identifiants

pubmed: 35652468
pii: 6598089
doi: 10.1093/jas/skac205
pmc: PMC9387601
pii:
doi:

Substances chimiques

Butyrates 0
Calcium Gluconate SQE6VB453K

Types de publication

Journal Article Randomized Controlled Trial, Veterinary

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Trouw Nutrition
Organisme : Natural Sciences and Engineering Council of Canada

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the American Society of Animal Science. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

J Nutr. 2002 Aug;132(8):2229-34
pubmed: 12163667
Nat Commun. 2014 Apr 29;5:3611
pubmed: 24781306
J Clin Invest. 1994 May;93(5):2263-6
pubmed: 8182159
J Dairy Sci. 1996 May;79(5):862-72
pubmed: 8792286
J Dairy Sci. 2017 Nov;100(11):9402-9417
pubmed: 28918138
J Anim Sci. 2005 Jan;83(1):89-97
pubmed: 15583047
J Endocrinol. 1991 Apr;129(1):55-8
pubmed: 2030330
Am J Physiol Regul Integr Comp Physiol. 2011 Jun;300(6):R1515-23
pubmed: 21451145
J Lipid Res. 2013 Sep;54(9):2325-40
pubmed: 23821742
J Anim Sci. 2020 Sep 1;98(9):
pubmed: 32815992
Am J Physiol Gastrointest Liver Physiol. 2009 May;296(5):G1098-107
pubmed: 19264953
J Dairy Sci. 2011 Jun;94(6):3002-13
pubmed: 21605770
J Dairy Sci. 2012 May;95(5):2680-4
pubmed: 22541496
J Dairy Sci. 2019 Aug;102(8):7556-7569
pubmed: 31229286
J Nutr. 2009 Sep;139(9):1619-25
pubmed: 19625695
Cell Biol Int. 1998;22(5):339-44
pubmed: 10198153
J Dairy Sci. 2019 Feb;102(2):1274-1280
pubmed: 30591339
Gastroenterology. 2002 Feb;122(2):531-44
pubmed: 11832466
Dig Dis Sci. 2012 Dec;57(12):3126-35
pubmed: 22684624
Am J Physiol Gastrointest Liver Physiol. 2018 Jul 1;315(1):G53-G65
pubmed: 29494208
J Anim Sci. 2006 Feb;84(2):370-8
pubmed: 16424265
J Dairy Sci. 1991 Oct;74(10):3583-97
pubmed: 1660498
J Dairy Sci. 2018 Apr;101(4):3099-3109
pubmed: 29397179
Comp Biochem Physiol Comp Physiol. 1993 Aug;105(4):705-9
pubmed: 8102959
Domest Anim Endocrinol. 2003 Mar;24(2):103-22
pubmed: 12586312
Biochem J. 1962 Jan;82:90-6
pubmed: 14007241
J Anim Sci. 2009 Oct;87(10):3317-34
pubmed: 19648500
Anal Biochem. 1985 Oct;150(1):76-85
pubmed: 3843705
J Dairy Sci. 2019 Dec;102(12):11681-11700
pubmed: 31606208
J AOAC Int. 2009 Jan-Feb;92(1):42-9
pubmed: 19382561
J Comp Physiol B. 2001 Apr;171(3):215-21
pubmed: 11352104
J Anim Sci. 2018 Feb 15;96(1):108-125
pubmed: 29385473
J Dairy Sci. 2021 Jul;104(7):7845-7855
pubmed: 33865576
Anim Sci J. 2016 Sep;87(9):1090-8
pubmed: 27150835
Comp Biochem Physiol B. 1987;86(3):439-72
pubmed: 3297476
Am J Physiol Regul Integr Comp Physiol. 2014 Oct 1;307(7):R802-16
pubmed: 25080498
Scand J Clin Lab Invest. 1984 Apr;44(2):169-72
pubmed: 6719024
Nutr Res Rev. 2010 Dec;23(2):366-84
pubmed: 20937167
Arch Tierernahr. 2001;55(2):85-102
pubmed: 12068484

Auteurs

Daniel H M Watanabe (DHM)

Department of Animal and Poultry Science, University of Saskatchewan, Saskatoon, Saskatchewan, Canada S7N 5A8.

John Doelman (J)

Trouw Nutrition R&D, PO Box 299, 3800 AG, Amersfoort, The Netherlands.

Michael A Steele (MA)

Department of Animal Biosciences, University of Guelph, Guelph, ON, Canada N1G 2W1.

Le L Guan (LL)

Department of Agricultural, Food and Nutritional Sciences, University of Alberta, Edmonton, AB, Canada.

Dave J Seymour (DJ)

Trouw Nutrition R&D, PO Box 299, 3800 AG, Amersfoort, The Netherlands.

John A Metcalf (JA)

Trouw Nutrition North America, 7504 McLean Road E., Puslinch, ON, N0B 2J0, Canada.

Gregory B Penner (GB)

Department of Animal and Poultry Science, University of Saskatchewan, Saskatoon, Saskatchewan, Canada S7N 5A8.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH